Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915
2003 ◽
Vol 94
(5)
◽
pp. 453-458
◽
2021 ◽
2005 ◽
Vol 11
(4)
◽
pp. 1572-1578
◽
2014 ◽
Vol 21
(S4)
◽
pp. 610-618
◽
2005 ◽
Vol 23
(2)
◽
pp. 165-170
◽